Enzalutamide reduced metastasis or death risk by 71 percent in phase III trial of castration-resistant nonmetastatic prostate cancer with escalating PSA.
from Featured Health News from Medical News Today https://ift.tt/2tRVuIM
Home
»
Featured Health News from Medical News Today
»
Health
» Medical News Today: Prostate cancer: New drug for aggressive, resistant cases
Subscribe to:
Post Comments (Atom)
Post a Comment